2022 annual financial data
Compass Therapeutics 2022 Operating cash flow margin
Direct answer
Operating cash flow margin was Not calculable.
Operating income was -41,655,000 USD and net income was -39,225,000 USD.
Operating cash flow was -34,125,000 USD.
Get free Compass Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -41,655,000 USD
- Net income
- -39,225,000 USD
- Operating cash flow
- -34,125,000 USD